Back to Search
Start Over
Reply to: Osimertinib Plus Antiangiogenic Agents: A Promising New Paradigm With Uncertain Results.
- Source :
-
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Feb 24, pp. JCO2500032. Date of Electronic Publication: 2025 Feb 24. - Publication Year :
- 2025
- Publisher :
- Ahead of Print
Details
- Language :
- English
- ISSN :
- 1527-7755
- Database :
- MEDLINE
- Journal :
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 39993244
- Full Text :
- https://doi.org/10.1200/JCO-25-00032